Corient Capital Partners’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$134K Buy
12,837
+2,320
+22% +$22.8K 0.01% 635
2022
Q2
$110K Sell
10,517
-1,716
-14% -$18.8K 0.01% 655
2022
Q1
$133K Sell
12,233
-1,250
-9% -$16.5K 0.01% 708
2021
Q4
$182K Sell
13,483
-1,395
-9% -$18.6K 0.01% 672
2021
Q3
$202K Sell
14,878
-1,486
-9% -$21.1K 0.01% 642
2021
Q2
$234K Buy
+16,364
New +$237K 0.02% 577
2021
Q1
Sell
-10,866
Closed -$204K 627
2020
Q4
$204K Buy
+10,866
New +$177K 0.02% 479
2017
Q3
Sell
-62,104
Closed -$2.41M 306
2017
Q2
$2.41M Buy
+62,104
New +$2.38M 0.37% 78
2017
Q1
Sell
-54,302
Closed -$2.07M 316
2016
Q4
$2.07M Buy
+54,302
New +$2.02M 0.37% 77

Other funds holding VTRS

Corient Capital Partners's VTRS Position: Q3 2022 in Review

Corient Capital Partners increased its Viatris (VTRS) stake by 22% in Q3 2022, buying an estimated $22.8K and bringing the position to 12,837 shares worth $134K. The position accounts for 0.01% of the portfolio, ranked #635.

Corient Capital Partners first reported a position in VTRS in Q4 2016 and has held it in 9 quarters since. The position peaked at $2.41M in Q2 2017. 980 funds tracked by Wall St. Rank hold VTRS as of Q3 2022.

  • Corient Capital Partners held 12,837 shares of Viatris worth $134K as of Q3 2022.
  • Corient Capital Partners bought 2,320 Viatris shares in Q3 2022, an estimated $22.8K.
  • Viatris made up 0.01% of Corient Capital Partners's portfolio in Q3 2022, its #635 holding.
  • Corient Capital Partners first reported a position in Viatris in Q4 2016 and has held it in 9 quarters since.
  • Corient Capital Partners's Viatris position peaked at $2.41M in Q2 2017.
  • 980 funds tracked by Wall St. Rank held Viatris as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.